Lava Therapeutics Bv

Lava Therapeutics Bv is located in Utrecht, Netherlands on Yalelaan 60. Lava Therapeutics Bv is rated 3 out of 5 in the category company in Netherlands. Lava Therapeutics B.V. is a start-up biotechnology company, founded in 2016, that creates and develops next generation γδ T-cell engaging bispecific antibodies for the treatment of cancer. Our first-in-class immuno-oncology approach activates γδ T cells in a tumor target dependent manner. The company’s proprietary γδ TCR-bispecific antibody platform originates from cutting-edge research by Dr. Hans van der Vliet’s group at the VU University Medical Center and Cancer Center Amsterdam. The objective of Lava Therapeutics B.V is to develop potent, safe and cost-effective biopharmaceuticals that arm the immune system to recognize and destroy tumor cells.